Literature DB >> 11260319

The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen-specific cytotoxic T-cell function.

J S Passmore1, P T Lukey, S R Ress.   

Abstract

Despite strong evidence for CD8+ T-cell function in murine mycobacterial infections, their corresponding role in human tuberculosis has proven more difficult to demonstrate. We have evaluated the human macrophage (Mphi) cell line U937 as an in vitro model for human leucocyte antigen (HLA) class I-restricted presentation of mycobacterial antigens, as HLA class I is constitutively expressed at high levels by U937 cells in the absence of detectable HLA class II or CD1 molecules. U937 cells were evaluated for their ability to phagocytose Mycobacterium tuberculosis and for their ability to present mycobacterial antigens to human HLA class I-matched cytotoxic T lymphocytes (CTLs). Differentiated U937 cells were capable of efficient phagocytosis of M. tuberculosis but did not generate a subsequent respiratory burst response, and were permissive for intracellular growth of both bacillus Calmette-Guérin (BCG) and the virulent M. tuberculosis H37Rv strain. CTL activity was restricted to live mycobacterial organisms and was shown to be mediated by M. tuberculosis-specific, HLA class I-matched, purified CD8+ CTL lines and CD8+ T-cell clones. Furthermore, M. tuberculosis-infected U937 targets were more rapidly and strongly lysed by CD8+ CTLs than were infected autologous Mphi. Finally, M. tuberculosis-infected U937 cells simultaneously provided a sensitive indicator for detection of mycobacterial-specific, HLA-unrestricted gammadelta+ CTL activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260319      PMCID: PMC1783164          DOI: 10.1046/j.1365-2567.2001.01164.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Mycobacterial infection of macrophages results in membrane-permeable phagosomes.

Authors:  R Teitelbaum; M Cammer; M L Maitland; N E Freitag; J Condeelis; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Mycobacteria-reactive Lyt-2+ T cell lines.

Authors:  G De Libero; I Flesch; S H Kaufmann
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

3.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

4.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

5.  In vitro induction of cytologic and functional differentiation of the immature human monocytelike cell line U-937 with phorbol myristate acetate.

Authors:  J O Minta; L Pambrun
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

6.  CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages.

Authors:  N V Serbina; C C Liu; C A Scanga; J L Flynn
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

7.  CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein.

Authors:  N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

8.  Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.

Authors:  D H Canaday; C Ziebold; E H Noss; K A Chervenak; C V Harding; W H Boom
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

9.  Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells.

Authors:  S M Smith; A S Malin; T Pauline; S E Atkinson; J Content; K Huygen; H M Dockrell
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

10.  Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis.

Authors:  S M Behar; C C Dascher; M J Grusby; C R Wang; M B Brenner
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

View more
  22 in total

1.  Granule-dependent cytolysis of Mycobacterium tuberculosis-infected macrophages by human gammadelta+ T cells has no effect on intracellular mycobacterial viability.

Authors:  J S Passmore; R H Glashoff; P T Lukey; S R Ress
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  Circulating gamma delta T cells in response to Salmonella enterica serovar enteritidis exposure in chickens.

Authors:  Angela Berndt; Jana Pieper; Ulrich Methner
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction.

Authors:  Jiu Deng; Xiuli Zhang; Zongzheng Chen; Yong Luo; Yao Lu; Tingjiao Liu; Zhengzhi Wu; Yu Jin; Weijie Zhao; Bingcheng Lin
Journal:  Biomicrofluidics       Date:  2019-03-07       Impact factor: 2.800

4.  Effects of mesenchymal stem cell and fibroblast coating on immunogenic potential of prosthetic meshes in vitro.

Authors:  Yue Gao; David M Krpata; Cory N Criss; Lijia Liu; Natasza Posielski; Michael J Rosen; Yuri W Novitsky
Journal:  Surg Endosc       Date:  2014-06-28       Impact factor: 4.584

5.  Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody.

Authors:  Kuen-Feng Chen; Hui-Ling Chen; Chung-Wai Shiau; Chun-Yu Liu; Pei-Yi Chu; Wei-Tien Tai; Kimihisa Ichikawa; Pei-Jer Chen; Ann-Lii Cheng
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  Identifying putative Mycobacterium tuberculosis Rv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells.

Authors:  Martha Forero; Alvaro Puentes; Jimena Cortés; Fabio Castillo; Ricardo Vera; Luis E Rodríguez; John Valbuena; Marisol Ocampo; Hernando Curtidor; Jaiver Rosas; Javier García; Gloria Barrera; Rosalba Alfonso; Manuel A Patarroyo; Manuel E Patarroyo
Journal:  Protein Sci       Date:  2005-09-30       Impact factor: 6.725

7.  Identification and characterization of PKF118-310 as a KDM4A inhibitor.

Authors:  Gianluigi Franci; Federica Sarno; Angela Nebbioso; Lucia Altucci
Journal:  Epigenetics       Date:  2016-10-21       Impact factor: 4.528

8.  Long-term maintenance of a microfluidic 3D human liver sinusoid.

Authors:  Ljupcho Prodanov; Rohit Jindal; Shyam Sundhar Bale; Manjunath Hegde; William J McCarty; Inna Golberg; Abhinav Bhushan; Martin L Yarmush; Osman Berk Usta
Journal:  Biotechnol Bioeng       Date:  2015-08-26       Impact factor: 4.530

9.  Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition.

Authors:  Malgosia K Matyszak; J S Hill Gaston
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice.

Authors:  Pierre Kyme; Nils H Thoennissen; Ching Wen Tseng; Gabriela B Thoennissen; Andrea J Wolf; Kenichi Shimada; Utz O Krug; Kunik Lee; Carsten Müller-Tidow; Wolfgang E Berdel; W David Hardy; Adrian F Gombart; H Phillip Koeffler; George Y Liu
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.